The present application provides a container for storage, preservation, identification, tracking and transport of a federally controlled substance comprising: (a) a one or more piece airtight container having an exterior surface and an interior surface, an upper portion and a lower portion, configured for containing a federally controlled substance; (b) an inner coating liner lining said interior surface of said airtight container; (c) a one piece tamper resistant easy open lid affixed to said upper portion of said airtight container; and (d) identifying indicia located on the exterior surface for identifying the contained federally controlled substance contents within said container; wherein said airtight container configured for containing a federally controlled substance, has the atmosphere evacuated and the container filled with an inert gas before the airtight container is hermetically sealed, containing a federally controlled substance inside.

A syringe assembly includes a barrel including a barrel body portion, a cylindrical barrel end portion disposed at a distal end of the barrel body portion, the cylindrical barrel end portion including an annular head portion and an annular recessed portion, and a puncture needle having a puncture needle tip and having a proximal end fixedly inserted into the barrel end portion; and a seal cap mounted to the barrel, the seal cap including a closed distal end portion, an open proximal end portion, a hollow portion including (i) a barrel end storage portion, the barrel end storage portion being configured to store the barrel end portion, and (ii) a puncture needle storage portion extending from a distal end of the barrel end storage portion, an insertion portion configured to receive the puncture needle tip, and a projection portion formed on an inner surface of the barrel end storage portion.

An environment control system utilizes oxygen and humidity control devices that are coupled with an enclosure to independently control the oxygen concentration and the humidity level within the enclosure. An oxygen depletion device may be an oxygen depletion electrolyzer cell that reacts with oxygen within the cell and produces water through electrochemical reactions. A desiccating device may be g, a dehumidification electrolyzer cell, a desiccator, a membrane desiccator or a condenser. A controller may control the amount of voltage and/or current provided to the oxygen depletion electrolyzer cell and therefore the rate of oxygen reduction and may control the amount of voltage and/or current provided to the dehumidification electrolyzer cell and therefore the rate of humidity reduction. The oxygen level may be determined by the measurement of voltage and a limiting current of the oxygen depletion electrolyzer cell. The enclosure may be a food or artifact enclosure.

The present invention relates to high purity cangrelor, pharmaceutical formulations comprising high purity cangrelor as an active ingredient, methods for preparing such compounds and formulations, and methods for using the pharmaceutical formulations in the inhibition of platelet activation and aggregation.

A package comprises an airtight container having an oxygen permeability of less than or equal to 15 ml/m.sup.2dMPa and water vapor permeability of less than or equal to 2 g/m.sup.2d, and a sub-nano membrane structure accommodated in the airtight container. The sub-nano membrane structure having a porous support and a sub-nano membrane. The sub-nano membrane formed on the porous support and having an average pore diameter of less than or equal to 1 nm.

The present invention relates to high purity cangrelor, pharmaceutical formulations comprising high purity cangrelor as an active ingredient, methods for preparing such compounds and formulations, and methods for using the pharmaceutical formulations in the inhibition of platelet activation and aggregation.

A pharmaceutical product includes a delivery syringe comprising a plastic receptacle and an oxygen-tight envelope which envelopes the delivery syringe in an oxygen-tight manner, wherein the plastic receptacle is filled with an oxygen-sensitive active pharmaceutical ingredient fluid and an inner surface of the plastic receptacle is siliconized at least in sections.

A method of reducing the deterioration of a wetted hydrophilic coating caused by sterilization by radiation is provided. The method comprises the step of incorporating a thiosulfate anion and a buffer into the wetting hydrophilic coating comprising water. Some embodiments of the invention relate to a wetted hydrophilic coating, a wetting agent, a package comprising a wetted hydrophilic coating, and a method of sterilizing a wetted hydrophilic coating.

A packaging that generates a protective atmosphere from a chemical reaction that generates carbon dioxide which is triggered by the natural exudate of the packaged product and which extends over time, such as to effectively control the generation of gases inside the packaging and avoiding build-up of exudate in contact with the food product inside said packaging.

A packaged product which comprises a solid object and a packaging that seals and holds the solid object, wherein a replacement gas is contained in a space sealed by the packaging when the packaging is sealed and wherein the solid object has absorbed a part of or all of the replacement gas.